Shuhei Yamaguchi Selected Research

Shuhei Yamaguchi Research Topics

Disease

13	Stroke (Strokes) 01/2023 - 01/2004
9	Brain Ischemia (Cerebral Ischemia) 01/2022 - 02/2010
6	Cognitive Dysfunction 07/2022 - 01/2004
5	Infarction (Infarctions) 01/2022 - 04/2010
5	Ischemic Stroke 12/2021 - 08/2005
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 05/2008
4	Hypertension (High Blood Pressure) 01/2019 - 06/2010
4	Ischemia 01/2019 - 02/2010
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 04/2010
3	Dementia (Dementias) 02/2017 - 05/2011
2	Inflammation (Inflammations) 01/2020 - 03/2011
2	Vascular Remodeling 01/2020 - 01/2011
2	Gastroesophageal Reflux (GERD) 04/2013 - 07/2006
2	Encephalitis (Encephalitis, Rasmussen) 06/2012 - 07/2008
2	Neuroinflammatory Diseases 03/2011 - 07/2010
1	Overweight 02/2023
1	Hyperbilirubinemia 05/2022
1	Obesity 05/2022
1	Brain Edema (Cerebral Edema) 01/2022
1	Multiple System Atrophy 12/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2021
1	Epiretinal Membrane (Epiretinal Membranes) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Lacunar Stroke 08/2018
1	Atrial Fibrillation 02/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Mood Disorders (Mood Disorder) 10/2017
1	Anorexia 10/2017
1	Neck Pain (Cervicalgia) 10/2017
1	Fever (Fevers) 10/2017
1	Low Back Pain (Lumbago) 10/2017
1	Cerebral Small Vessel Diseases 01/2017
1	Guillain-Barre Syndrome 01/2015
1	Dermatomyositis (Dermatopolymyositis) 10/2014
1	Nocardia Infections 01/2014
1	Rubella (German Measles) 09/2013
1	Mumps 09/2013
1	Hemorrhagic Stroke 07/2013
1	Aspiration Pneumonia 04/2013

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2017
4	Cystatin CIBA 01/2020 - 05/2008
4	EnzymesIBA 10/2018 - 07/2009
3	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 05/2008
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2008
3	AntibodiesIBA 09/2013 - 07/2005
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2012 - 08/2005
2	Cysteine Proteinase InhibitorsIBA 01/2020 - 01/2011
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2011
2	Yi-Gan SanIBA 12/2012 - 05/2011
2	ropinirole (Requip)FDA LinkGeneric 06/2012 - 06/2010
2	Dopamine (Intropin)FDA LinkGeneric 06/2012 - 06/2010
2	Dopamine Agonists (Dopamine Agonist)IBA 06/2012 - 06/2010
2	Nerve Growth Factors (Neurotrophins)IBA 07/2010 - 04/2010
1	vasectrin I (VS I)IBA 02/2023
1	PowdersIBA 07/2022
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	GlobulinsIBA 05/2022
1	AlbuminsIBA 05/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2022
1	AntioxidantsIBA 03/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2022
1	rho-Associated KinasesIBA 01/2022
1	Complement C1r (Complement Component 1r)IBA 12/2021
1	histidine-rich proteinsIBA 12/2021
1	Complement C1q (C1q Complement)IBA 12/2021
1	CellophaneIBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	CholesterolIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	ChemokinesIBA 10/2018
1	argatroban (MPQA)FDA Link 08/2018
1	EdaravoneIBA 08/2018
1	Thrombin FDA Link 08/2018
1	ozagrelIBA 08/2018
1	Dabigatran FDA Link 02/2018
1	edoxabanIBA 02/2018
1	apixabanIBA 02/2018
1	Warfarin (Coumadin)FDA LinkGeneric 02/2018
1	Vitamin K FDA Link 02/2018
1	AnticoagulantsIBA 02/2018
1	RivaroxabanIBA 02/2018
1	Serotonin (5 Hydroxytryptamine)IBA 10/2017
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2017
1	Docosahexaenoic AcidsIBA 02/2017
1	HemosiderinIBA 01/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015
1	tocilizumab (atlizumab)FDA Link 10/2014
1	Amikacin (A.M.K)FDA LinkGeneric 01/2014
1	rubella antibodiesIBA 09/2013
1	Antihypertensive Agents (Antihypertensives)IBA 07/2013

Therapy/Procedure

8	Transplantation 01/2020 - 02/2010
6	Therapeutics 08/2018 - 05/2004
2	Enteral Nutrition (Feeding, Tube) 04/2013 - 07/2006
2	Gastrostomy 04/2013 - 07/2006
2	Thrombolytic Therapy 01/2012 - 08/2005
1	Secondary Prevention 02/2018
1	Cell Transplantation 01/2016
1	Lasers (Laser) 11/2013
1	Catheters 04/2013